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INTRODUCTION 
 
 
Micturating cystourethrogram is a basic investigation in three important urological 
conditions in children - 1.Posterior urethral valves (PUV) 2.Neurogenic bladder (NB) and 
3.Vesicoureteric reflux (VUR). While on the one hand these conditions may mimic one 
another, on the other, there is a degree of true overlap as in reflux secondary to 
dysfunctional voiding, neurogenic bladder and posterior urethral valves. Therefore it is 
imperative to make a correct diagnosis in these cases and to differentiate these conditions 
from each other as the management of each condition is different. 
 
               Ureteric reimplantation is the primary surgical treatment in vesicoureteric 
reflux, but is of secondary importance in neurogenic bladder and posterior urethral 
valves. Similarly, fulguration is the treatment of choice in posterior urethral valves, but is 
harmful in neurogenic bladder, misdiagnosed as posterior urethral valves. It is not 
uncommon to misdiagnose neurogenic bladder as PUV because a dilated urethra is seen 
in both and in the absence of clinically recognizable neural stigmata like 
meningomyelocoele (MMC) and sacral agenesis, these cases can be misdiagnosed as 
PUV and treated inappropriately. This is especially important when we are dealing with 
nonneurogenic neurogenic bladder (NNNB) cases. 
 
       While the posterior urethral dilatation in PUV has been quantified in the recent 
literature [1, 2, 3] similar quantification is not available in neurogenic bladder. This study 
is an attempt to quantify the posterior urethral dilatation on micturating 
3 
 
cystourethrograms in boys with neurogenic bladder and compare it with that in posterior 
urethral valves and in boys who have had a micturating cystourethrogram but neither had 
neurogenic bladder nor posterior urethral valves (control group). 
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AIMS AND OBJECTIVES 
 
 
 
1. To assess the posterior urethral dilatation  on micturating cystourethrogram by  using 
posterior urethra to bulbar urethral ratio in boys with neurogenic bladder and to 
compare it with that in  posterior urethral valves and normal controls. 
 
2. To assess whether there is any correlation between upper tract changes in neurogenic 
bladder patients and the dilatation of posterior urethra, as quantified by using urethral 
ratio. 
 
3. To assess whether the urethral ratio in neurogenic bladder patients has any correlation 
with the age of the child at first diagnosis. 
 
4. To assess whether posterior urethral dilatation is any different in neurogenic bladder 
caused by meningomyelocoele verses sacral agenesis. 
 
5. To assess whether posterior urethral dilatation has any association with bladder 
compliance in neurogenic bladder. 
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                                         REVIEW OF LITERATURE 
 
EMBRYOLOGY OF MALE URETHRA: 
 
The embryology of urethra is not completely understood, particularly as it 
pertains to pathologic anomalies. The proximal or posterior urethra is formed by 
differentiation of the urogenital sinus, and the anterior urethra results from tubularization 
of the urethral plate. 
 
The urethra is usually divided into four sections: 
1. The prostatic urethra, which is defined from the bladder neck to the proximal 
portion of urogenital diaphragm. 
2. The membranous urethra or that portion that traverses the diaphragm 
3. The bulbar urethra that segment from the membranous urethra to the penoscrotal 
junction 
4. The penile urethra which traverses the penile shaft and the glans. 
 
Between the fourth and seventh week of gestation the cloaca subdivides into a 
posterior portion (anorectal canal) and an anterior portion (primitive urogenital 
sinus).The urogenital sinus then develops into a cranial portion that dilates to form the 
urinary bladder and pelvic portion that forms the proximal prostatic urethra and the 
membranous urethra .The anterior urethra is formed from the urethral folds on the genital 
tubercle. That portion of the urethra unlike the posterior urethra is dependent on 5 alpha 
reductase [4]. 
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Fig 1: Development of male urethra 
 
 
STRUCTURAL ANATOMY OF LOWER URINARY TRACT: 
 
          The whole anatomic unit that stores and eliminates urine is called bladder and the 
smooth muscle in the bladder wall is called the detrusor [5]. The detrusor consists of 
numerous interlacing muscle bundles that interdigitate with one another in an intricate 
fashion, resulting in a complex meshwork of smooth muscle [6]. There are no identifiable 
continuously separate layers of the detrusor. This arrangement is such that when the 
detrusor contracts there is reduction in the size of the bladder in all dimensions, resulting 
in efficient emptying. The muscle fibers of the detrusor continue into the bladder neck 
and also surround the proximal urethra. Although the muscles of the detrusor and bladder 
neck are smooth, unlike other types of smooth muscle they are under voluntary control. 
          The urethral sphincter mechanism is composed of smooth and striated muscle 
components. The smooth muscle component consists of the continuation of the detrusor 
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into the vesical neck and proximal urethra. This is called the internal urethral sphincter. 
The striated component surrounds and is integral with the urethra where it passes through 
the urogenital diaphragm. This is called the external urethral sphincter and is composed 
of both slow and fast twitch muscle fibers .The slow twitch capability of these fibers 
allows a more sustained contraction than normal striated muscle and the striated sphincter 
is therefore able not only to close the urethra acutely but also to maintain passive 
continence for prolonged periods of time. 
               Because the smooth (internal) and striated (external) sphincters have different 
nerve supplies, their function in providing urinary continence is independent of each 
other. The smooth muscle sphincter at the bladder neck (internal sphincter) is however 
the primary continence mechanism [7]. 
               In a normal bladder intravesical pressure during voiding is exerted evenly 
against all points of the internal bladder wall. This pressure compresses the submucosal 
portion of the distal ureter against the detrusor behind it resulting in a functional closure 
that prevents reflux. 
                The normal bladder has viscoelastic properties that allow it to stretch 
significantly without an attendant rise in tension. Positional changes of the patient or 
increased abdominal pressure occurring with straining or coughing result in a significant 
rise in the intravesical pressure; however because the increased pressure is distributed 
equally to both bladder and the urethra, there is no net change in the pressure gradient 
between the two, and continence is preserved [5]. 
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NEUROANATOMY OF NORMAL VOIDING:  
 
The micturition reflex is a complicated neurologic event governing voiding that 
requires integration of multiple neural pathways. 
 
Pontine micturition center: 
Integration of the micturition reflex occurs in the pontine micturition center, 
located in the brain stem. A number of suprapontine pathways connect the cerebral cortex 
with the pontine micturition center, and provide voluntary cerebral control over the 
micturition reflex. 
 
Sacral micturition center: 
It is located in the second through fourth sacral cord segments, and a pathway in 
the spinal cord connects it with the pontine micturition center. Another neural pathway in 
the spinal cord connects the motor cortex of the brain with the pudendal nucleus, which 
also is located in the second through fourth sacral cord segments; the purpose of this 
pathway is to enable voluntary contraction of the external sphincter by the pudendal 
nerve [5]. 
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Fig 2: Neuroanatomy of brain, brain stem, and spinal cord neural pathways involved 
micturition. 
 
Peripheral nerves: 
Activation, coordination, and integration of various parts of the bladder-
sphincteric complex involves both the central somatic and autonomic nervous systems 
through three sets of peripheral nerves: sacral parasympathetic (pelvic nerve), 
thoracolumbar sympathetic (hypogastric nerves and sympathetic chain), and sacral 
somatic nerves (primarily the pudendal nerve) [8-9]. 
Parasympathetic nerve fibers run in the pelvic nerve (S2 to S4) to supply the 
pelvic and vesical plexuses before entering the bladder. Parasympathetic ganglia are 
found within these plexuses and in the bladder wall. Sympathetic nerves arise from 
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segments T10 to L2 of the spinal cord and go to the inferior mesenteric ganglion through 
the sympathetic trunk. From the inferior mesenteric ganglion the nerve fibers pass to the 
pelvic plexus and bladder through the hypogastric nerves. There is also sympathetic 
innervation originating from T10 to L2 supplying the detrusor and urethral sphincter [10]. 
The somatic nervous system (pudendal nerve) supplies the periurethral pelvic floor 
musculature [9]. The sensory and motor nerves carried by all three nerves innervate both 
the bladder and urethral sphincter. They originate from parasympathetic ganglia located 
in the second, third, and fourth segments of the sacral spinal cord [10]. Within the spinal 
cord, information from bladder afferents is integrated with that from other viscera and 
somatic sources and projected to the brain stem centers that coordinate the micturition 
cycle [11]. 
 
Fig 3: Neuroanatomy of sacral reflex arc. 
11 
 
Although detrusor control is predominantly parasympathetic, the sympathetic 
nervous system can block parasympathetic conduction, preventing premature detrusor 
contractions and maintaining tone of the internal sphincter at the bladder neck. The 
sympathetics therefore, serve to modulate the storage of urine [5]. 
 
NEUROPHYSIOLOGY OF NORMAL VOIDING: 
 
Normally as the bladder fills there is a complex, unconscious inhibition of the 
micturition reflex by the suprapontine pathway. As the bladder distends to near its 
capacity, a need to void is transmitted to sensory centers in the brain. Then, when voiding 
is necessary and can occur in a socially acceptable situation, the micturition reflex is 
consciously activated. 
              The micturition reflex allows coordinated voiding, which involves, in the 
following order, relaxation of the external urethral sphincter, contraction of detrusor and 
finally opening of the internal sphincter. During voiding sympathetic pathways are 
deactivated; also, opening of the internal sphincter results in funneling of the bladder 
base. Pressure in the widely patent urethra during voiding is the same as that in the 
bladder. Interruption of the urinary stream may be accomplished by voluntary contraction 
of the external urethral sphincter. Any urine remaining in the proximal urethra is then 
milked back into the bladder by the internal sphincter [5]. 
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Fig 4: Diagram of normal voiding. A - In the normal continent state the urethra is closed 
throughout by sphincters at the bladder neck and urogenital diaphragm. B - During 
normal voluntary voiding, the external sphicters at the level of the urogenital diaphragm 
relaxes, the bladder detrusor muscle contracts,and the bladder neck funnels.Pressure 
during voiding is the same in the bladder lumen and urethra. C - Upon completion of 
voiding, the external sphincter is consciously contracted. D - Urine remaining in the 
proximal urethra is milked back into the bladder by the internal sphincter fibers that 
surround this area. 
  Under normal conditions, the detrusor muscle, bladder neck, and striated external 
sphincter function as a synergistic unit for adequate storage and complete evacuation of 
urine. When a neurourologic lesion exists, these components usually fail to act in unison.  
Multiple classification systems have been proposed to link these various 
neurologic disease processes and to provide and their resultant voiding dysfunction [12]. 
The classification based on the reflexivity of the detrusor is a gross simplification of 
neurogenic bladder and allows understanding the basic pathophysiology involved in 
lesions at various levels. Simply put, lesions of the sacral reflex arc (lower motor neuron) 
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typically result in detrusor areflexia; lesions above this level result in detrusor 
hyperreflexia [5]. 
 
 
1. Detrusor Areflexia:  
Typically, it is secondary to neurologic lesions affecting the sacral micturition 
center or pathways connecting this center with the bladder (or both). In most cases the 
urethral sphincter mechanism remains competent. Because there is no perception of 
bladder distension, the bladder will fill until the viscoelastic properties of the smooth 
muscle fibers in its wall are exceeded; intravesical pressure then rises and eventually 
exceeds that exerted by the urethral sphincter mechanism. At this point overflow 
incontinence occurs until the pressures are equalized, at which point incontinence ceases. 
In yet other cases of detrusor areflexia the sphincter mechanism may be compromised, 
resulting in a continual dribbling incontinence of urine. If some urethral sphincter activity 
remains, however, the patient can maintain continence by emptying the bladder regularly 
with abdominal straining or the credes maneuver. The amount of residual urine is 
dependent on the effectiveness of these adjunctive voiding mechanisms. 
Conditions that result in detrusor areflexia include lower spinal cord tumors, herniated 
intervertebral disc, trauma or pelvis surgery that damage the pelvic or pudendal nerves 
(or both) of the sacral reflex arc. 
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2. Detrusor Hyperreflexia: 
There are two subgroups of detrusor hyperreflexia. 
a) Lesion in cerebral cortex: Causes uninhibited bladder contractions, but 
micturition reflex is intact, and voiding, even when completely involuntary, is 
physiologically coordinated. 
b) Lesion in suprasacral spinal cord: Micturition reflex is disrupted and voiding, 
when it occurs, is frequently uncoordinated, because of Detrusor external 
sphincter dyssynergia (DESD) 
 
Detrusor hyperreflexia caused by lesions of the suprasacral spinal cord are more 
ominous because of the potential for upper urinary tract damage. DESD occurs in up to 
three fourths of patients with suprasacral spinal cord lesions. 
In DESD the external urethral sphincter contracts involuntarily at the same time a 
bladder detrusor contraction occurs, thus impeding urinary flow because of increased 
urethral resistance [13]. Normal contractions of the external urethral sphincter are 
voluntary and allow purposeful interruption of the urinary stream. With disruption of the 
suprasacral pathways, the normal coordination between the detrusor and the external 
sphincter often is not possible. When this type of uncoordinated voiding occurs, 
intravesical pressure may become very high. This increased pressure is a major factor in 
causing upper urinary tract deterioration. 
Common neurologic disorders of the suprascaral spinal cord resulting in this type 
of detrusor hyperreflexia include dysraphic myelodysplasia, spinal cord trauma and 
spinal cord tumors. 
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PATHOPHYSIOLOGY OF UPPER TRACT CHANGES IN NEUROGENIC 
BLADDER: 
 
In patients with NBSD, disordered innervation of the detrusor musculature and 
external sphincter adversely affects bladder function. Children with this condition can be 
categorized into high-risk and low-risk groups for secondary damage from a neurogenic 
bladder based on intravesical pressure. When the detrusor (filling) pressure exceeds 
40 cm H2O, glomerular filtration rate decreases and pyelocaliceal and ureteral drainage 
deteriorates, leading to obstructive hydronephrosis and/or vesicoureteral reflux [14-17]. 
Even in the absence of reflux or upper urinary tract dilatation, high intravesical pressure 
can impair drainage of urine into the bladder. Any pathophysiologic process that causes 
either intermittent or continuous elevation of bladder pressure above 40 cm H2O places 
the child at risk for upper urinary tract dysfunction, urinary tract infections, and 
ultimately renal failure. Intermittent elevation of bladder pressure may occur from 
detrusor hypertonia, hyperreflexia, or both. Hyperreflexia may cause intermittent 
elevation of bladder pressure, especially if the external sphincter acts reflexively and 
tightens rather than relaxes in an attempt to prevent micturition [detrusor external 
sphincter dyssynergia (DESD)]. Over a long period of time, hyperreflexia with pressures 
greater than 40 cm H2O may result in detrusor decompensation (areflexia from myogenic 
failure) or in detrusor hypertrophy with associated sacculations and subsequent 
diverticula formation. These pathophysiologic changes affect the elastic and vesicoelastic 
properties of the bladder and also result in mechanical ureterovesical junction 
obstruction. Continuous elevation of bladder pressure above 40 cm H2O may occur from 
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a hypertonic detrusor or a hypertrophic small-capacity bladder secondary to outflow 
obstruction [18]. Bladder outlet obstruction is caused by DESD, or by fibrosis of the 
external urethral sphincter secondary to partial or complete denervation [19-21]. Bladder 
outlet obstruction will lead to elevated (pathologic) voiding pressures, which will 
contribute to either detrusor decompensation or hypertrophy. Finally, recurrent urinary 
tract infections due to bladder residue may aggravate damage to the neurogenic bladder 
through processes of transmural inflammation and fibrosis. Together with high 
intravesical pressures and/or vesicoureteral reflux, these lower urinary tract infections 
will lead to episodes of acute pyelonephritis and irreversible renal damage. 
 
PATHOPHYSIOLOGY OF URETHRAL DILATION IN NEUROGENIC 
BLADDER: 
 
Posterior urethral dilation is mainly seen in patients with neurogenic bladder who 
have associated detrusor external sphincter dyssynergia (DESD).In these patients, during 
voiding, the external sphincter at the level of urogenital diaphragm contracts involuntarily 
and inappropriately. This lack of co-ordination between the bladder detrusor and external 
sphincter contractions causes functional outlet obstruction at the level of membranous 
urethra [5], causing increased pressure in the proximal urethra (as well as in the bladder 
lumen), that results in significant widening of the prostatic urethra and resultant dilatation 
[4]. 
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Fig 5: Neurogenic bladder with detrusor external sphincter dyssynergia. 
 
The posterior urethral dilatation can be seen in other conditions affecting the 
vesicourethral unit, as in posterior urethral valves and in nonneurogenic neurogenic 
bladder. Though the pathophysiology of posterior urethral dilatation in these conditions 
may be different, on imaging studies they may simulate each other, and hence can cause 
diagnostic confusion. 
Trabeculated bladder 
Dilated posterior urethra 
External sphincter 
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PATHOPHYSIOLOGY OF URETHRAL DILATION IN PUV: 
 
              In patients with posterior urethral valves, there is mechanical obstruction to the 
passage of urine due to presence of valves in the prostatic urethra. This leads high 
voiding pressures which distend and thin the prostatic urethra. The storage capacity of the 
prostatic urethra sometimes exceeds that of the bladder because of the relative lack of 
muscle there. The verumontanum is distorted, and the ejaculatory ducts may be dilated 
from refluxing urine. The bladder neck is rigid and hypertrophied. Bladder neck 
appearance and function usually improve after the obstructive valves are destroyed.  
 
 
 
 
Fig 6: Posterior urethral valves 
Trabeculated bladder 
Dilated posterior urethra 
Obstructing valve
Dilated tortuous ureters 
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MICTURATING CYSTOURETHROGRAM FEATURES IN DIFFERENT 
CONDITIONS: 
 
MCU in neurogenic bladder: 
In children with neurogenic bladder dysfunction the easily recognized 
radiological findings on voiding cystourethrogram are most often attributable to 
dyssynergia between the detrusor muscle and external sphincter. They represent a 
combination of transient functional changes, that is irregular mucosal pattern, hourglass 
bladder configuration and saccular dilatation of the posterior urethra, as well as chronic 
morphological abnormalities, including contracted bladder, “pine-tree” shaped bladder 
,trabeculation and pseudodiverticulum of the bladder wall [22]. With the recently 
developed understanding of neurogenic bladder and its treatment, in most cases the 
radiologic patterns of fully developed disease are no longer seen. 
 
MCU in Nonneurogenic neurogenic bladder :  
 
Hinman [23] described an apparent ‘syndrome’ of voiding dysfunction that 
mimics neuropathic bladder disease but may be a learned disorder. It is produced by an 
active contraction of the sphincter during voiding, creating a degree of outflow 
obstruction. 
 Radiologic features include large-capacity, trabeculated bladder,reflux: III/V in degree, 
large residual urine volume, posterior urethra sometimes dilated with narrowing at 
external sphincter. 
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MCU in Posterior urethral valves : 
 
In PUV, the MCU often demonstrates bladder diverticula and severe 
vesicoureteral reflux. From the lateral projection, the bladder neck is elevated and the 
proximal urethra is dilated, and the actual valve structure is often visible. 
 
Shopfner and Hutch as well as Popek et al have hypothesized that the posterior 
urethra has the capacity to stretch with increased voiding pressure due to its unique 
histological and anatomical configuration, in contrast to the anterior urethral segment [24, 
25]. Hence, on  micturating cystourethrogram, the posterior urethra may look dilated in 
neurogenic bladder, PUV and nonneurogenic neurogenic bladder, though the 
pathophysiology of posterior urethral dilatation is different  in all these  conditions. 
Therefore it is imperative to make a correct diagnosis in these cases and to differentiate 
these conditions from each other as the management of each condition is different. 
 
 Few authors have studied the changes in the anatomical configuration of 
posterior urethra pre and post fulguration in posterior urethral valves; however a 
comparison of the dilatation of posterior urethra in neurogenic bladder patients with that 
of posterior urethral valves and cystoscopically normal boys has not been studied so far. 
 
O. Bani Hani et al from the Childrens Hospital at Westmead, Australia, performed 
a study on 23 infants to provide a ratio to measure successful treatment of posterior 
urethral valves. Median preoperative ratio was 8.6 and it decreased postoperatively to 3.1. 
They concluded that calculating urethral ratio in patients with posterior urethral valves 
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allows objective measurement of the technical success of valve ablation [1]. Similar 
study was carried out by Gupta et al in India, and they concluded that calculation of 
urethral ratio on VCUG for assessment of outcome of fulguration is objective, 
reproducible, and allows preoperative and postoperative VCUG from different facilities 
to be compared. In their study, mean urethral ratio in pre-fulguration group was 4.94 (SD 
2.97) and they found that a post-fulguration urethral ratio of 2.5-3 represents an 
acceptable result postoperatively [2]. 
Menon et al from PGIMER Chandigarh, India, carried out a study on 217 patients 
to assess the morphological normalization of posterior urethra on MCUG 3 months after 
fulguration and correlated these changes with the overall clinical status of the patients. As 
the pre and post fulguration MCUG may be taken by different Xray machines and in 
different setup, the ratio of the diameter of PU to that of the BU was taken .This ratio is a 
useful tool in predicting severity of the disease and objectively assesses the adequacy of 
fulguration independent of the surgeon’s opinion. They found a significant reduction in 
the dimensions of the posterior urethra and an increase in the dilatation of the anterior 
urethra, especially the bulbar urethra, after a successful valve fulguration. They 
concluded  a post operative PU/BU ratio >3 SD(1.92)  should alert to an incomplete 
fulguration or stricture and  patients with normal range ratio have faster recovery of slow 
draining units ,reflux and less voiding dysfunction [3]. 
All these studies are done in PUV patient’s pre and post fulguration, however so 
far no study has been published which has quantified the dilatation of posterior urethra in 
neurogenic bladder patients and compared it with that in PUV and cystoscopically normal 
urethra as in primary VUR.  
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URODYNAMICS IN NEUROGENIC BLADDER: 
 
The applicability of urodynamic testing has expanded so much that most pediatric 
urologic centers consider functional assessment of the lower urinary tract an integral 
element in the evaluation process and as important as radiographic visualization in 
characterizing and managing these abnormal conditions [14, 19]. Urodynamic studies 
fulfill several objectives: [14, 19, 26, 27] 
 They provide baseline information about the radiologic appearance of the upper 
and lower urinary tract, as well as the condition of the sacral spinal cord and the 
CNS. 
 The studies can then be compared with later assessments, so that early signs of 
deteriorating urinary tract drainage and function, or of progressive neurologic 
denervation, can be detected. 
 They help to identify babies at risk for urinary tract deterioration as a result of 
detrusor hypertonicity or outflow obstruction from detrusor–sphincter dyssynergy, 
which then allows prophylactic measures to be initiated before the changes 
actually take place. 
 They help the physician to counsel parents with regard to their child’s future 
bladder and sexual function. 
 
Three categories of lower urinary tract dynamics:  
1. Synergic. 
2. Dyssynergic, with and without detrusor hypertonicity.  
3. Complete denervation 
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1. Synergy is characterized by complete silencing of the sphincter during a detrusor 
contraction or when capacity is reached at the end of filling. Voiding pressures are 
usually within the normal range. 
2. Dyssynergy occurs when the external sphincter fails to decrease, or actually increases 
its activity during a detrusor contraction or a sustained increase in intravesical 
pressure, as the bladder is filled to capacity [28]. Frequently, a poorly compliant 
bladder with high intravesical pressure is seen in conjunction with a dyssynergic 
sphincter, resulting in a bladder that empties only at high intravesical pressures [20]. 
3. Complete denervation is noted when no bioelectric potentials are detectable in the 
region of the external sphincter at any time during the micturition cycle or in response 
to a Credé maneuver or sacral reflex stimulation. 
 
Categorizing lower urinary tract function in this way is extremely useful because 
it defines which children are at risk for urinary tract changes, who should be treated 
prophylactically, who needs close surveillance, and who can be followed at greater 
intervals without fear of deterioration. 
 
 On initial assessment or subsequent studies, 71% of newborns with dyssynergic 
voiding have urinary tract deterioration within the first 3 years of life, whereas only 17% 
of synergic voiders and 23% with completely denervated sphincter developed similar 
changes. Thus, it appears that outlet obstruction is a major contributor to the development 
of urinary tract deterioration in these children. 
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 Although videourodynamics is the state-of-the-art modality for evaluating 
complex or refractory neurogenic bladder, it is currently available only in few centers in 
India, and hence many patients does not have access to this sophisticated study. 
  
TREATMENT OF NEUROGENIC BLADDER: 
 
At birth, the majority of patients with neurogenic bladder have normal upper 
urinary tracts. Without proper management, urinary tract infections and elevated bladder 
pressures with secondary bladder-wall changes may cause upper urinary tract 
deterioration within 3 years in up to 58% [29]. One third of children who develop 
impaired kidney drainage do so within the first year of life [30]. Crucial for long-term 
prognosis of patients with neurogenic bladder sphincter  dysfunction  is the fact that the 
management must start before consequences of bladder dysfunction become apparent. 
 
The goals of management are to prevent or minimize secondary damage to the 
upper urinary tracts and bladder from the primary neurogenic bladder dysfunction and to 
achieve safe social continence [31]. Thus, long before continence becomes an issue, 
starting from the first year of life, management is directed at creating a low-pressure 
reservoir and ensuring complete and safe bladder emptying. 
 
Clean intermittent catheterization (CIC) in combination with anticholinergics 
(oxybutynin) is the standard therapy for children with neurogenic bladder dysfunction 
with detrusor hyperactivity and/or DESD [18, 32, 33]. This treatment is also feasible and 
effective in developing countries, where untreated neuropathic bladder is an important 
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cause of preventable chronic renal failure [34, 35]. CIC enables complete bladder 
emptying and thus avoids bladder residues and consequent risks for infections. In the 
high-risk bladder with DESD, CIC also allows bladder emptying before the occurrence of 
otherwise “spontaneous” high-pressure voiding, which is known to be detrimental for 
kidney function and drainage. Parental acceptance of, and compliance with, clean 
intermittent catheterization appears to be far greater if it has been used consistently from 
birth.  
 
Oxybutynin, a bladder smooth-muscle relaxant, is used to improve bladder 
dynamics through suppression of detrusor hypertonicity and hyperreflexia. By doing so, 
oxybutynin eliminates (high-pressure) uninhibited detrusor contractions (and thus urinary 
leakage) and prevents high-pressure bladder storage (due to detrusor hypertonicity or low 
bladder compliance) and high-pressure emptying (in case of DESD).  
 
When a hyperreflexic or hypertonic bladder fails to respond to these measures, 
augmentation cystoplasty may be required. However, the need for this operative modality 
in children managed proactively has been substantially reduced to 17%, as compared 
with a 41% incidence in children followed expectantly [36,37]. Furthermore, the use of 
vesicostomy drainage has been almost completely eliminated since this approach has 
been adopted. 
 
Given the success of other specialties (physical medicine and rehabilitation, 
orthopedics, and neurology) at improving and prolonging the lives of the neurologically 
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impaired patient,we as paediatric surgeons  have  an increasing responsibility to evaluate 
and treat the neurogenic bladder  effectively as early as it is detected and  over a life span 
that is approaching that of the normal population. 
 
SUMMARY OF REVIEW OF LITERATURE:                                                       
 
We have summarized the review of literature by the following headings: 
1. Anatomy of male vesicourethric unit. 
2. Physiology of vesicourethric unit. 
3. Abnormal physiology in neurogenic bladder. 
4. Structural changes caused by the abnormal function and the typical changes in 
micturating cystourethrogram due to this. 
5. Possible effect on the upper tracts due to these functional and structural changes in 
the vesicourethric unit in neurogenic bladder. 
 
In this study, we are interested in the quantification of urethral changes and its 
possible relation if any with the upper tract changes in neurogenic bladder and its 
comparison with Posterior urethral valves and cystoscopically normal controls. 
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MATERIAL AND METHODS 
 
Study design: This is a retrospective case control study of male children with a diagnosis 
of neurogenic bladder, posterior urethral valve and control patients (vesicoureteric 
reflux), treated for their respective conditions in the Department of Paediatric surgery, 
Christian Medical College and Hospital(CMC), Vellore, India; between January 2007 to 
October 2010. The micturating cystourethrograms of all these 197 patients were studied 
and urethral ratio was calculated in all patients. A detailed study of neurogenic bladder 
boys with respect to their posterior urethral dilatation was done. 
 
A. Patient groups: 
                     Three groups of patients were studied and urethral ratio was calculated from 
their Micturating cystourethrograms. 
 
Group No of patients 
Neurogenic bladder (NB) 73 
Posterior urethral valve (PUV) 75 
Control (VUR) 49 
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Group 1: Neurogenic bladder. 
                    
                  A total of 73 boys diagnosed as neurogenic bladder with a proven cause 
(congenital or traumatic) were included in this group. 
 
Inclusion criteria: 
 
a) Boys with congenital neural tube defects in the form of either             
meningomyelocoele (n=56), lipomeningocoele (n=5), sacral agenesis (n=7) or 
occult spinal dysraphism with tethered cord syndrome (n=3) as proven by MRI. 
b) Boys with acquired cause in the form of spinal trauma alone without pelvic injury 
(n=2) 
 
Exclusion criteria: 
 
a) Patients with nonneurogenic-neurogenic bladder.                                              
b) Neurogenic bladder associated with anorectal malformation (ARM). 
c) Neurogenic bladder secondary to spinal cord tumors. 
d) Neurogenic bladder secondary to intracranial pathology, eg, cerebral palsy. 
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Group 2: Posterior urethral valves : 
 
                 A total of 75 patients diagnosed and treated for posterior urethral valves, who 
had a preoperative micturating  cystourethrogram done under fluoroscopy in radiology 
department of CMCH, and were primarily  treated  in  CMC hospital  were included  in 
this group.               
 
 Exclusion criteria: 
a) Boys who underwent fulguration of Posterior urethral valves in other hospitals 
and then underwent cystourethrogram in CMCH with check cystoscopy and 
refulguration or any other operative procedure were excluded from the study. 
b) Boys who had a micturating cystourethrogram done on the operating table under 
image intensifier in CMCH were excluded as proper oblique images were not 
available in those patients. 
 
Group 3: Control patients: 
 
A total of 49 boys who had undergone cystoscopy prior to ureteric reimplantation 
for primary vesicoureteric reflux were taken as control patients. 
 
Inclusion criteria: 
Boys who underwent cystoscopy for primary VUR and on cystoscopy found to 
have a normal urethra and bladder. 
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Exclusion criteria: 
Patients who had any abnormality in the urethra or trabeculation in the bladder 
wall on cystoscopy were excluded. 
 
Note that cystoscopy rather than radiology was used as criterion for normality to avoid 
a radiological bias.  
  
B. Calculation of urethral ratio in  micturating cystourethrogram: 
     The micturating cystourethrograms (MCU) were studied retrospectively and 
urethral ratio was calculated in all 197 patients. The MCU’s were performed under 
fluoroscopy with both the paediatric surgeon and the radiologist present during the study. 
 
Definition of urethral ratio (UR): 
    We defined urethral ratio (UR) as the diameter of the posterior urethra (PU) 
divided by the diameter of the anterior urethra (AU), measured during the voiding phase, 
on an oblique film of a micturating cystourethrogram 
 
Measurement of urethral ratio [1] [2] 
The diameter of the posterior urethra was measured transversely at a point 
halfway between the bladder neck and the distal end of the membranous urethra. The 
diameter of the anterior urethra was measured as a transverse diameter at the point of 
maximum distension in the bulbar urethra .All the measurements were done on a voiding 
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film, in oblique position without a catheter. Both measurements were taken on the same 
film and then a urethral ratio was calculated.  
 
C. Additional data for neurogenic bladder patients (n=73 boys): 
              Since the focus of this study is mainly on neurogenic bladder, additional data 
was collected for these 73 boys. 
        
1) Base line patient information: 
i. Age:  Boys with neurogenic bladder between the age group of 5 months to 15 
years of age were included. 
 
Group Age(year) No. of patients (n=73) % 
Infancy < =1 10 13.7 
Preschool 2-5 27 36.99 
Primary school 6-10 24 32.88 
High school 11-15 12 16.44 
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ii. Etiology of NB: The cause of neurogenic bladder was studied only congenital 
neural tube defect patients excluding ARM were taken in the study. Two cases of 
spinal trauma presenting as neurogenic bladder were also included. 
 
Cause of NB No. of patients % 
Meningomyelocoele 56 76.7 
Lipomeningocoele 5 6.85 
Sacral agenesis 7 9.59 
Spina bifida occulta 
with tethered cord 
3 4.11 
Spinal trauma 2 2.74 
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2) Radiological investigations: 
i) Micturating cystourethrograms (MCU) –  
MCU’s were studied with respect to the following parameters- 
a) Bladder trabeculation 
b) Vesicoureteric reflux 
c) Posterior urethral dilatation. 
                                 
NB  Patients No. of patients 
VUR present 20 
Unilateral 12 
Bilateral 8 
VUR absent 53 
 
 
ii) Ultrasonography (USG) : 
The following parameters were studied on USG in each patient- 
a) Upper tract changes in the form of hydroureteronephrosis, and whether 
unilateral or bilateral. 
b) Bladder thickening / trabeculations. 
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Upper tract changes (HUN) No  of  patients N=73 % 
Present (unilateral/bilateral) 21 28.76 
Absent 52 71.24 
 
21 boys (28.76 %) with NB, had upper tract changes in the form of 
hydroureteronephrosis at presentation, while 52 (71.24 %) had normal upper tracts at 
presentation. Statistical correlation between upper tract changes and urethral ratio was 
calculated. 
  
3) Cystometrogram (CMG) - 
CMGs if available were studied and any statistical correlation between CMG 
finding and urethral ratio was assessed. A total of 22 patients underwent CMG. 
 
Bladder Compliance No. of patients (N=22) % 
Good 5 22.72 
Poor 17 77.28 
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4) Treatment: 
All neurogenic bladder patients were studied for the mode of treatment i.e 
medical /surgical. Medical management included mainly CIC and anticholinergic drugs 
(oxybutinin). Few patients required surgery in the form of either diversion 
(vesicostomy/ureterostomy) or bladder augmentation. 
 
Treatment No of NB patients (n=73) % of NB patients 
Medical 63 86.3 
Surgical 10 13.7 
 
 
D. Statistical Methods: 
Data entry was undertaken by a single investigator using Microsoft excel. Data 
analysis was done using Statistical Package for Social Version 15.Comparison of urethral 
ratios between three groups of patients was made using multiple comparisons (ANOVA) 
and statistical difference sought. T-test was used to assess if there is any statistical 
difference in the urethral ratio in different age groups, patients with or without upper tract 
changes and compliance on CMG. 
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RESULTS AND ANALYSIS 
 
1. Patient Group Vs Urethral ratio (UR): 
                 
Micturating cystourethrograms of all patients were studied and Urethral ratio was 
calculated in all three groups. 
 
Patient group Mean UR 
 
Range 
Std. 
Deviation 
95% Confidence 
Interval for Mean ANOVA 
p value Lower 
Bound 
Upper 
Bound 
Controls (n=49) 1.28 0.5-3.2 0.47 1.15 1.42 
0.000 
Neurogenic 
bladder (n=73) 2.92 0.8-8.4 1.68 2.53 3.31 
Posterior urethral 
valves (n=75) 5.12 1.06-13.9 2.85 4.46 5.78 
 
The mean urethral ratio in control patients was 1.28 (SD 0.47), with a range of 0.5 
to 3.2. In neurogenic bladder mean (SD) was 2.92 (1.68), with a range of 0.8 to 8.4 and in 
Posterior urethral valves it was 5.12 (2.85) and a range of 1.06 to 13.9. 
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                                                    Multiple Comparisons 
(I) 
GROUPS 
(J) 
GROUPS 
Mean Difference 
(I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
1 
2 -1.594 .000 -2.511 -.677 
3 -3.836 .000 -4.748 -2.924 
2 
1 1.594 .000 .677 2.511 
3 -2.241 .000 -3.057 -1.425 
3 
1 3.836 .000 2.924 4.748 
2 2.241 .000 1.425 3.057 
 
On  comparing the urethral ratio between all three groups of patients, the  urethral 
ratio in neurogenic bladder patients was significantly higher than controls (p<0.05) and 
lower than PUV patients, similarly, the urethral ratio in PUV patients was significantly 
higher than both the other groups (p<0.05) 
 
Graph showing distribution of urethral ratio in all three groups expressed as   
percentage of the population. 
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Graph Showing distribution of Urethral Ratio in Each Group: 
 
                  CONTROL                           NB                                       PUV 
                          
Though the mean urethral ratio was different in each of the group, there was some 
overlap in the U.R between the control group and neurogenic bladder and also between 
neurogenic bladder and PUV group. 
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2. Age at presentation Vs Urethral ratio: 
 
Age Group(years) 
N=73 
 
Mean 
UR 
 
Range 
 
S.D 
95% Confidence  Interval 
for Mean P value 
lower 
bound 
Upper 
bound 
Infancy (<=1) 2.96 0.8-5.65 1.71 1.73 4.18 
0.529 
Preschool (2-5 ) 
 2.55 0.9-7.5 1.50 1.95 3.14 
Primary school 
(6-10) 3.20 0.86-8.44 1.74 2.46 3.94 
High school 
(11-15) 3.18 1.1-7.18 1.97 1.92 4.43 
 
The mean age of neurogenic bladder patients at presentation was 6.02. The mean 
urethral ratio was highest 3.2 (SD 1.74) in the primary school age group, and lowest in 
the 2 to 5 age group 2.55 (SD 1.50). There was no correlation between age at presentation 
with neurogenic bladder and the urethral ratio (p=0.529) 
 
Age group Vs Mean UR:  
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Multiple Comparisons 
(I) 
Age_rec
1 
(J) 
Age_rec
1 
Mean Difference 
(I-J) 
Sig. 
95% Confidence Interval 
Lower Bound Upper Bound
< =1 yr 
2-5 yr .405 1.000 -1.299 2.111 
6-10 yr -.245 1.000 -1.979 1.488 
11-15 yr -.226 1.000 -2.198 1.746 
2-5 yr 
<=1 yr -.405 1.000 -2.111 1.299 
6-10 yr -.651 1.000 -1.943 .641 
11-15 yr -.631 1.000 -2.230 .966 
6-10 yr 
<=1 yr .245 1.000 -1.48 1.979 
2-5 yr .651 1.000 -.641 1.943 
11-15 yr .019 1.000 -1.609 1.648 
>11 yr 
<=1 yr .226 1.000 -1.746 2.198 
2-5 yr .631 1.000 -.966 2.230 
6-10 yr -.019 1.000 -1.648 1.609 
 
On comparing different age groups, no statistical correlation was found between 
age at presentation with neurogenic bladder and urethral ratio (p>0.05) 
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3. Cause of neurogenic bladder Vs urethral ratio: 
 
Cause of NB 
n=68 
 
Mean UR 
 
S.D 
95% confidence interval of 
the difference P value
 
Lower Upper 
 
MMC+LipoMc 
n=61 
2.96 1.78 -0.88 1.86 
0.477 
 
Sacral agenesis 
n=7 
2.46 0.90 -0.39 1.38 
 
The mean urethral ratio in MMC+Lipomeningocoele group was 2.96 while in sacral 
agenesis patients it was 2.46. However, in patients with MMC and lipomeningocoele as 
compared with sacral agenesis, no statistically significant difference in urethral ratio was 
found. 
 
Cause of NB Vs Mean UR: 
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4. Upper tract changes Vs Urethral ratio: 
Upper tract changes (HUN) 
N=73 Mean UR S.D S.E P value 
Present(n=21) 3.53 1.92 0.420 
0.049 
Absent(n=52) 2.67 1.53 0.212 
 
In boys who had neurogenic bladder with upper tract changes, the mean (SD) 
urethral ratio was 3.53(1.92), while in those without upper tract changes, it was 2.67 
(1.53). Thus, the urethral ratio in boys with neurogenic bladder who had upper tract 
changes (in the form of hydroureteronephrosis on USG) was significantly higher than in 
those boys without upper tract changes (p<0.05) 
 
Upper tract changes Vs Mean UR: 
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Graph showing distribution of UR Vs Upper tract changes in neurogenic bladder: 
                        
 
                  Present                    Absent 
                                                     Upper tract changes 
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5. Upper tract changes according to age group Vs mean UR:  
Upper tract 
changes in 
Age group 
N=21 
 
Mean 
UR 
 
S.D 
95% Confidence 
Interval for Mean Range p 
value Lower 
Bound 
Upper 
Bound Min Max 
 
Infancy 
(n=3) 
3.37 2.07 -1.7835 8.5035 1.62 5.65 
0.999 
 
Preschool 
(n=2) 
 
3.59 1.14 -6.7020 13.8820 2.78 4.40 
 
 Primary 
school (n=9) 
 
3.54 2.09 1.9204 5.1396 1.86 8.44 
 
High school 
(n=7) 
3.58 2.21 1.5324 5.6219 1.10 7.18 
 
Upper tract changes according to age group Vs mean Urethral Ratio:  
 
In patients with upper tract changes, the mean urethral ratio (3.59) was highest in the 
preschool age group, and lowest in infancy (3.37) 
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Multiple Comparisons 
(I) 
Age_rec 
(J) 
Age_rec 
Mean 
Difference (I-J)
Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
<=1 yr 
2-5 yr -.23000 1.000 -5.9246 5.4646 
6-10 yr -.17000 1.000 -4.3287 3.9887 
11-15 yr -.21714 1.000 -4.5218 4.0876 
2-5 yr 
<=1 yr .23000 1.000 -5.4646 5.9246 
6-10 yr .06000 1.000 -4.8165 4.9365 
11-15yr .01286 1.000 -4.9888 5.0145 
6-10 yr 
<=1 yr .17000 1.000 -3.9887 4.3287 
2-5 yr -.06000 1.000 -4.9365 4.8165 
11-15 yr -.04714 1.000 -3.1909 3.0966 
11-15 yr 
<=1 yr .21714 1.000 -4.0876 4.5218 
2-5 yr -.01286 1.000 -5.0145 4.9888 
6-10 yr .04714 1.000 -3.0966 3.1909 
 
On comparison of the urethral ratio in boys with neurogenic bladder having upper tract 
changes (hydroureteronephrosis on USG) in the different age groups, no statistically 
significant difference was found between the urethral ratio and the age group.   
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6. Bladder compliance on CMG Vs Urethral ratio: 
COMPLIANCE MEAN UR S.D 
95% confidence interval of 
the difference p Value 
Lower Upper 
NORMAL (n=5) 1.79 1.08 -2.71 -0.19 
0.026 
POOR (n=17) 3.24 1.21 -2.78 -0.12 
 
The mean (SD) urethral ratio in neurogenic bladder patients with poor compliance 
on CMG was 3.24 (SD 1.21) which was significantly higher (p<0.05) than in those with 
normal compliance 1.79 (SD 1.08). 
 
 Compliance Vs Mean Urethral Ratio: 
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SUMMARY OF RESULTS: 
 
1. On  comparing the urethral ratio between all three groups of patients, the mean  
urethral ratio in neurogenic bladder (2.92) was significantly higher than controls 
(1.28) (p<0.05) and lower than PUV patients, similarly, the urethral ratio in PUV 
patients (5.12) was significantly higher than both the other groups (p<0.05). 
 
2. There was no statistically significant difference found between age at presentation 
with neurogenic bladder and the urethral ratio. 
 
3. In patients with meningomyelocoele and lipomeningocoele as compared with sacral 
agenesis, no statistically significant difference in urethral ratio was found. 
 
4. In neurogenic bladder patients with upper tract changes, the mean (SD) urethral ratio 
was 3.53(SD 1.92), while in those without upper tract changes, it was 2.67(SD1.53). 
Thus, the urethral ratio was significantly higher in neurogenic bladder with upper 
tract changes than in those without upper tract changes (p<0.05) 
 
5. The mean (SD) urethral ratio in neurogenic bladder patients with poor compliance on 
CMG was 3.24(SD1.21) which was significantly higher (p<0.05) than in those with 
normal compliance 1.79(SD 1.21). 
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DISCUSSION 
The majority of patients with neurogenic bladder are born with structurally 
normal upper tracts, unlike patients with posterior urethral valves. Thus much of the 
renal damage is acquired after birth, except in some cases of sacral agenesis where 
structural problems such as solitary kidney may considerably increase the risk of 
renal failure. In neurogenic bladder, there is a behavioural problem with the bladder 
and the urethral sphincter –the vesicouretheric unit. Proper behaviour expected of the 
vesicouretheric unit is a quiet bladder during storage and a quiet sphincter during 
voiding. A bladder which is ‘active’ during storage (neurogenic detrusor overactivity) 
and a sphincter that is active during voiding (detrusor sphincter dyssynergia) is the 
most common and most dangerous type of problem seen in neurogenic bladder. Over 
a period of time, or sometimes very quickly, this leads to bladder muscle hypertrophy, 
collagen deposition, high pressure storage and secondary vesicoureteric reflux -much 
the picture of Posterior urethral valves. Hence it is imperative to distinguish the 
neurogenic bladder and especially non-neurogenic neurogenic bladder from PUV, as 
the management of all these conditions differs. 
The micturating cystourethrogram forms the basic investigation in PUV, 
neurogenic bladder and vesicoureteric reflux (± dysfunctional voiding), however 
there are some limitations of this study, as the bladder, posterior urethra and upper 
tracts may appear identical in all these conditions, and hence may cause diagnostic 
confusion and inappropriate management. The posterior urethra has a tremendous 
capacity to stretch with increased voiding pressure due to its unique histological and 
anatomical configuration and hence a dilated posterior urethra may be found 
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whenever there is disturbance in the vesicourethric unit. In this study we have 
compared this dilatation of posterior urethra on micturating cystourethrograms of 
neurogenic bladder boys, Posterior urethral valves and vesicoureteric reflux with a 
cystoscopically normal urethra (control group). 
O.Bani Hani from Australia and Gupta et al and Menon et al from India have 
published studies on PUV patients where the authors have quantified the posterior 
urethra to bulbar urethral ratio on micturating cystourethrograms , pre and post 
fulguration, and concluded that reduction in the urethral ratio in the post-fulguration 
MCU  can be considered as an objective evidence of adequacy of valve fulguration 
[1,2,3]. We have utilized this calculation of urethral ratio in patients with neurogenic 
bladder and compared it with PUVs and controls. 
This present study consists of 73 neurogenic bladder boys, 75 PUV patients and 
49 control patients. In choosing the cases of neurogenic bladder we have taken only 
those boys with proven neurological lesion in spinal cord while nonneurogenic 
neurogenic bladder cases were excluded. Since MCU and cystourethroscopy is not 
generally done in normal boys, as Controls we have taken boys with primary 
vesicoureteric reflux who underwent MCU and cystoscopy prior to reimplantation, 
ruling out cases with evidence of bladder trabeculation. The cystourethroscopy rather 
than radiology was taken as guideline for defining normality in these cases to avoid 
bias. We have calculated the urethral ratio on the MCU in all these three groups of 
patients and found that the urethral ratio in neurogenic bladder patients was 
significantly higher (mean 2.92, SD 1.68) than in the control group (mean1.28, SD 
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0.47), but lower than that in the posterior urethral valves (Mean5.12, SD 2.85), but 
still all three groups had a overlap of their ratios. 
             In our study we have attempted to study whether the dilatation of posterior 
urethra increases according to the age of the child at presentation with neurogenic 
bladder. Though the mean urethral ratio was highest (3.2) in the primary school age 
group(6-10years), and lowest (2.55) in the preschool (2 to 5 years) age group no 
correlation between age at presentation with neurogenic bladder and the urethral ratio 
(p=0.529) was found. It is a known fact that the neurourologic lesion in 
myelodysplasia is a dynamic disease process with changes taking place throughout 
childhood, [38-40] especially in early infancy, [30] and then at puberty, [41] when the 
linear growth rate accelerates again. Fifteen to 20 percent of newborns have an 
abnormal urinary tract on radiologic examination when first evaluated [42]. Without 
proper management, urinary tract infections and elevated bladder pressures with 
secondary bladder wall changes may cause upper urinary tract deterioration within 3 
years in upto 58% of patients [29]. 
                   We have compared the urethral ratio in two groups of neurogenic bladder 
patients, first group was meningomyelocoele and lipomeningocoele (UR=2.96) taken 
together and other group was sacral agenesis (UR=2.46).Our study does not show any 
statistically significant difference in the dilatation of posterior urethra in these two 
groups of patients, however the number of sacral agenesis (N=7) patients are far 
fewer than MMC+Lipomeningocoele (N=61). Although prognosis is believed to be 
correlated with the type and severity of neural tube defects (NTD), and in general, 
MMC is considered more severe than sacral agenesis or caudal regression syndrome 
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(CRS), there are no studies in the literature comparing the long-term urologic 
outcome in different populations of neural tube defects. Studies have shown that 
myelomeningocele accounts for more than 90% of all open spinal dysraphic states 
[43] and almost 100% of them have some degree of neurologic impairment. Sacral 
agenesis is not always associated with neuropathic bladder (NB) but can present as 
different urologic patterns with a great variability. Torrea et al have compared 
urologic outcome of patients with CRS as compared with MMC. They concluded that 
61% of patients with CRS and 98% of those with MMC had NB, and the functional 
prognosis of renal function was not better in those with CRS than in MMC [44]. 
               In this study we have analysed whether amount of posterior urethral 
dilatation has any relation to the upper tract changes in neurogenic bladder. In those 
with upper tract changes (as shown by hydroureteronephrosis on USG), the mean 
urethral ratio was 3.53(SD1.92), while in those without upper tract changes it was 
2.67 (SD1.53). Thus, the urethral ratio was significantly higher  in those with upper 
tract changes (p<0.05)  and hence quantification of  posterior urethral dilatation can 
be correlated with hydronephrosis .Past studies have shown that serum creatinine 
values and ultrasound imaging do not provide a sensitive measure of early renal 
injury, as changes may arise only after significant renal damage. Therefore, can we 
consider severity of posterior urethral dilatation in DESD as an indicator of 
progressive renal deterioration? Expectant treatment has revealed that infants with 
bladder outlet obstruction in the form of DESD are at considerable risk for urinary 
tract deterioration. Hence more the severity of bladder outlet obstruction, more will 
be the dilatation of posterior urethra and more will be the upper tract deterioration. It 
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is a proven fact that elevated detrusor pressures and recurrent urinary tract infections 
are the primary risk factors for renal deterioration and may be prevented by 
appropriate care of the lower tract [16, 45]. 
Although different aspects of the urologic treatment of children with 
myelodysplasia may be emphasized at different points in their lives (such as 
continence, sexual function, ease of catheterization), the ultimate challenge is to 
maintain normal upper urinary tracts by preventing renal injury.  
We have also analysed whether the neurogenic bladder boys, who present at a 
later age have more chances of upper tract deterioration as compared to those who 
present early, and the relation of posterior urethral dilatation in these patients. 
However no statistical correlation was found between these parameters. We have not 
found any studies in the literature stating this correlation. 
We routinely perform cystometrograms in neurogenic bladder cases at first visit 
and subsequently, to see for compliance and to rule out DESD. In this study we have 
noticed that the urethral dilatation was significantly higher in those with poorly 
compliant bladder (Mean UR 3.24), and less in those with good compliance (Mean 
UR 1.79). We feel that as the bladder outlet obstruction increases the posterior urethra 
dilates more and the compliance decreases, and this has been proved by our study. 
Studies have shown that sequential urodynamic testing on a yearly basis beginning in 
the newborn period and continuing until the child is 5 years old provides a means of 
carefully monitoring these children to detect signs of change. Approximately 10% of 
newborns with myelomeningocele exhibit no abnormality on urodynamic testing [46]. 
Most children who undergo changes tend to do so in the first 3 years of life [47].  
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Risk factors such as decreased bladder compliance and high leak point bladder 
pressure should be recognized early to initiate clean intermittent catheterization, 
anticholinergic drug treatment and prophylactic antibiotics rational therapy with CIC 
and anticholinergics depends on proper diagnostic tools. Undoubtedly, 
cystometrogram (CMG) is a valuable tool in the follow up of treatment, especially in 
regard to bladder compliance. 
In the present study we wish to emphasize that the posterior urethral dilatation 
exists not only in posterior urethral valves but also in many cases of neurogenic 
bladder, especially in those at risk for upper tract changes. Though as compared to 
PUV, posterior urethral dilatation is less in neurogenic bladder, it definitely has a 
overlap with PUV. Posterior urethral dialatation does not seem to have relation with 
age of the child, but it definitely shows correlation with renal damage and bladder 
compliance and thus is a diagnostic and prognostically important finding in MCU.As 
a extrapolation of the results obtained from our study, it is important to recognize the 
posterior urethral dilatation in cases of non-neurogenic neurogenic bladder who have 
no other stigmata of neurological disease and thus may be confused with PUV. The 
quantification of urethral ratios in our study should help in making this important 
differentiation.  
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                                         CONCLUSION 
 
1. Posterior urethra is significantly dilated in boys with neurogenic bladder 
compared with normal controls. 
2. The posterior urethral dilatation in neurogenic bladder is less than that in the 
posterior urethral valves, although there is a overlap in both groups. 
3. Boys with neurogenic bladder and upper tract changes showed significantly 
higher urethral ratio as compared with those without upper tract changes. 
4. Neurogenic bladder with poor compliance has significantly higher urethral ratio          
than those with normal compliance on cystometrogram. 
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ABBREVATIONS 
 
PUV – Posterior urethral valves 
 
NB – Neurogenic bladder 
 
VUR – Vesicoureteric reflux 
 
MMC – Meningomyelocoele  
 
NNNB – Nonneurogenic neurogenic bladder 
 
MCU – Micturating Cystourethrogram 
 
DESD – Detrusor external sphincter dysfunction 
 
CIC – Clean intermittent catheterization. 
 
UR – Urethral ratio 
 
AU – Anterior urethra 
 
PU – Posterior urethra 
 
CMG – Cystometrogram  
 
LipoMC – Lipomeningocoele 
 
NTD – Neural tube defect 
 
USG – Ultrasonography 
 
 
. KEY TO MASTERSHEET 
 
Cause of NB= cause of neurogenic bladder 
1= Meningomyelocoele 
2= Lipomeningocoele 
3= Sacral agenesis 
4= Spina bifida occulta with tethered cord 
5= Spine trauma 
 
U.R= URETHRAL RATIO 
 
HN=hydronephrosis on ultrasound 
1= Present 
2= Absent 
 
BLD TRAB= Bladder trabeculation 
1= Present 
2= Absent 
 
REFLUX 
1= Present 
2= Absent 
 
P.U DILN= Posterior urethral dilatation on MCU report. 
1= Present 
2= Absent 
 
CREAT=Creatinine 
 
PVR= Postvoid residue 
 
TREATMENT 
1= CIC 
2= CIC+Oxybutynin 
3= CIC+Oxybutynin+Amitryptiline 
4= Oxybutynin only 
5= Diversion 
6= Bladder augmentation+/- Mitrafanoff. 
 
CMG= cystometrogram 
1= Normal compliance 
2= Poor compliance. 
 
 
SR.NO HOSP NO NAME AGE CAUSE OF NB U.R HN BLD TRAB REFLUX PU DILN CREAT PVR TREATMENT CMG
1 589608C GEETHA'S BABY 4 1 0.909091 2 1 2 2 0.5 1 1 1
2 244473D  LATHA'S BABY 1 1 1.234615 2 2 2 2 0.4 2 1
3 242207D AMIT MATHEW THOMAS 3 2 7.5 2 1 2 2 0.5 1 2
4 369214D KAVIYARASU 13 1 7.183099 1 1 2 1 0.7 1 2
5 199189D DEBU HALDAR 0.5 1 4.860465 2 2 1 1 0.4 1 1
6 321693D MUNNA KUMAR 12 1 2.105263 1 1 1 2 2.4 1 1
7 083763D DHANRAJ SARVESH 3 3 2.232143 2 2 2 2 0.5 1 1
8 338592D MD.SHAHEED ALAM 6 1 2.538462 1 1 1 2 0.8 1 5
9 109534C SATHISH M 6 1 1.861111 1 1 2 1 0.6 1 5
10 405224C SUMATHIS BABY 3 1 1.025641 2 2 2 2 0.4 1 1
11 315567D TANMAY SAHU 14 2 1.105528 1 1 2 2 0.6 1 2
12 202545D YUVRAJ 10 1 8.444444 1 1 2 1 0.8 1 1
13 833388B VELMURUGAN 8 1 6.463158 2 1 2 1 0.6 1 1
14 267157D RANGARAJ 10 1 2.391304 2 1 2 1 0.5 2 2
15 235725C PRABHAVATHI'S BABY 6 1 2.082927 2 2 2 1 0.6 2 6
16 986509C RAJU 5 1 2.78022 1 1 1 2 0.6 2 6
17 019336D JAMSHEDUDDIN 7 3 2.125984 1 1 2 2 0.5 2 1
18 815795C RAJKUMAR 1 1 0.8 2 2 2 2 0.4 2 1 1
19 090466D AYUSHKUMAR VARMA 2 1 1.20202 2 2 2 2 0.4 1 3
20 099149D MALAY BERA 1 1 1.18239 2 2 2 2 0.4 1 2
21 822076C AKASH SARKAR 2 1 4.409091 1 1 1 1 0.7 2 6
22 034947C GEETHA'S BABY 5 1 1.006623 2 2 2 2 0.5 2 4 2
23 024609D MUKESHKUMAR 8 1 2.120482 2 1 2 1 0.7 1 1
24 962196C LIYAKAT ALI 8 1 3 2 1 2 1 0.5 1 2
25 896802C KONMAN 2 1 1.966292 2 2 2 2 0.4 2 1
26 015891D KRISHNA SUMANTH 15 1 1.51375 2 2 2 2 0.6 2 1 2
27 121664D VINAYAK 12 1 1.611289 1 1 1 2 0.4 1 1
28 036123D VINEET VICTOR 6 1 3.227513 1 1 2 1 0.5 2 2 2
29 765698C SUDIP DAS 2.5 1 1.706093 2 2 2 2 0.4 1 2
30 522749B VIGNESH 11 1 5.560811 2 2 2 1 0.6 2 6
31 838989C SELVI'S BABY 1 4 2.818182 1 1 1 1 0.5 2 1
32 965407C SWAGATAM DAS MANDAL 2 1 3.945 2 1 2 1 0.4 1 2 2
33 158360D TARNI SEN MANDAL 12 1 2.07029 2 2 2 2 0.5 1 1
34 426226C SHAHEED BANDWA 3.5 1 1.864489 2 2 2 1 0.4 1 1
35 927255C SURYA S 5 1 1.497485 2 2 2 2 0.5 2 2
36 436775D ANANDA GIRI 8 1 3.055556 1 1 1 + 0.6 2 6
37 390506D BHABATOSH 13 3 3.132552 1 1 1 1 1.6 2 6 2
38 453779D DEVA 9 1 2.857143 1 1 2 1 1.4 2 1 2
39 458458D ESTIAQUE.A 8 1 0.866667 2 1 1 2 0.6 2 2
40 949577C GAUTHAM 4 4 1.441176 2 1 1 2 0.4 1 5 2
41 239030D JHUMA BAGACHI'S BABY 1 1 1.628788 1 2 1 1 0.4 2 5
42 406579D KUMARAN 2 3 1 2 1 2 2 0.4 2 1
43 384236D MAYANK SHARMA 3 1 2.988372 2 2 2 1 0.5 2 2
44 652058B MOHD SAINAN 6 1 5.302419 1 1 2 1 0.5 1 2
45 564805D NILESH KUMAR OJHA 2 2 1.022222 2 1 2 2 0.4 1 1
46 555344D PRITAM C 8 1 1.337079 2 2 2 2 0.7 1 1 1
47 171030C RANJITH  KUMAR 8 1 4.66055 2 1 2 1 0.6 1 1 2
48 3970686C SABITRIDEVI'S BABY 5 1 3.891176 2 1 2 1 0.6 1 2 2
49 481149D SAMRAT GHOSH 2 1 4.929293 2 1 2 1 0.4 1 2
50 598707D SAMU 14 1 5.226415 1 1 2 1 0.6 1 2 2
51 386855D SANTHANA KUMAR 9 1 5.075 2 1 2 1 0.5 2 2
52 426226C SHAHIL BURNWAL 5 1 2.757396 2 2 2 2 0.4 1 2
53 491208D SHARIERAAHAMED 8 1 1.223404 2 1 2 2 0.6 1 2
54 517658D SHUBHAM KUMAR 14 1 2.137931 2 1 2 1 0.6 1 4
55 499755D SUDIP KUMAR 4 2 3.10101 2 1 2 1 0.6 1 4 1
56 440086D SUJAL GUPTA 1 2 3.053846 2 2 2 1 0.5 2 1
57 444227D SUSHANT SHURAV 5 1 2.817647 2 2 1 2 0.5 1 2
58 396904D TANMOY SAHA 7 5 2.824818 2 2 2 1 0.6 1 4
59 955364C USHA'S BABY 0.5 1 5.658824 1 2 2 + 0.5 2 2
60 512448D VIJAY SARKAR RAMUL 4 1 1.64 2 2 1 2 0.4 1 2
61 029535D VIJAYALAKSHMI'S BABY 2 1 2.7875 2 1 1 1 0.5 1 1 1
62 743963C ADRITA DEB 8 3 3.919753 2 1 2 1 0.5 2 2 2
63 642833D DEPARPAN MUKHERJEE 2 3 2.398333 2 1 2 2 0.5 2 4 2
64 653744D DINESH KUMAR YADAV 10 1 2.163636 2 1 1 1 0.6 2 3
65 433405C JAMES 6 1 3.234043 2 1 2 1 0.5 2 1 2
66 639592D LALPEKHLUA 2.5 1 2.171429 2 1 1 2 0.5 2 2 2
67 683355D PRIYANSHU 7 1 3.666667 2 1 2 1 0.6 1 1 2
68 743295D RAGHAVI NATHAN 0.8 4 4.26 2 2 2 1 0.5 1 1
69 696075D SABARINATHAN T 12 1 1.852174 2 1 1 2 0.6 2 1
70 720259D SHIVSAGAR SHAH 14 5 4.707071 1 1 2 1 1 1 2 2
71 683878D TORIQUL ISLAM 8 3 2.437403 1 2 1 2 0.6 2 2
72 499241C DEEPA'S BABY 5 1 3.918083 2 1 1 2 0.7 2 1
73 819651D ARNAB HOTA 1 1 4.081244 2 2 2 2 0.4 2 3 2  
 
 
 
SR.NO NAME HOSP NO RATIO NAME HOSP NO RATIO NAME HOSP NO RATIO
1 GEETHA'S BABY 589608C 0.91 DEBASHISH SHAW 129817D 5.38 ADITYA KUMAR 217415D 1.06
2  LATHA'S BABY 244473D 1.23 DISANT PRADHAN 003841D 6.81 AJAY PAUL 733425C 1.63
3 AMIT MATHEW THOMAS 242207D 7.50 DHANUSH  806392D 3.16 AMAN RAJ 782802D 1.02
4 KAVIYARASU 369214D 7.18 AMAN VERMA 169767D 4.92 ARIB NOOR FAROOQI 287000D 0.85
5 DEBU HALDAR 199189D 4.86 AYAN KONAR 790466C 9.22 ARPIT RAJ 458298D 2.47
6 MUNNA KUMAR 321693D 2.11 MANOMAY CHAKRABORTY 509241C 2.59 AYUSH KEDIA 386337D 1.18
7 DHANRAJ SARVESH 083763D 2.23 SABARNA KARMAKAR 798701D 1.77 BIKRAM RIT 331021D 1.76
8 MD.SHAHEED ALAM 338592D 2.54 RAMANA 915292C 7.07 BILOMBO BASAK 445039D 1.00
9 SATHISH M 109534C 1.86 PARUEZ BADSHA 087170D 7.23 BIVEK KUMAR 704128D 1.30
10 SUMATHIS BABY 405224C 1.03 PRADEEP 961355C 7.89 CHITRAS BABY 629131D 1.08
11 TANMAY SAHU 315567D 1.11 NITYA BERA 104512D 4.19 DEEPAK M 210904D 1.03
12 YUVRAJ 202545D 8.44 NITHISH KUMAR 078495D 13.53 DHEMAN ROY 254057D 0.98
13 VELMURUGAN 833388B 6.46 YASWANTH 033455D 6.08 DHINESH KUMAR 756190C 0.98
14 RANGARAJ 267157D 2.39 VINAYAGAM 630448C 1.06 FERODES BEGAM'S BABY 859140C 0.92
15 PRABHAVATHI'S BABY 235725C 2.08 USHAS BABY 955364C 4.29 GAURAV MASTER 594328D 1.17
16 RAJU 986509C 2.78 SHRIKANT JANA 989392C 6.01 HEENAKAR THAKUR 490448D 1.15
17 JAMSHEDUDDIN 019336D 2.13 SREEJAN KESARI 168445D 1.23 IBAN KITLANG 298651D 1.13
18 RAJKUMAR 815795C 0.80 SUMAN SUTRADHAR 156299D 3.08 JASWANT S 472637D 1.17
19 AYUSHKUMAR VARMA 090466D 1.20 SHAMEERA BANUS BABY 073037D 2.56 KUTU 664852C 0.94
20 MALAY BERA 099149D 1.18 SUBRAJIT DEB 077900D 6.40 KRISHNENDU PAL 393686D 1.33
21 AKASH SARKAR 822076C 4.41 ASHOK RANJAN S 885484C 3.05 LACKI 116793D 1.03
22 GEETHA'S BABY 034947C 1.01 ANBU D 238246D 3.94 MEERAJ MONDAL 535880D 1.16
23 MUKESHKUMAR 024609D 2.12 ANJALI DEVIS BABY 885965C 4.56 MOHD AMASH 983190C 3.25
24 LIYAKAT ALI 962196C 3.00 BABU 245960D 5.28 MOHD JASEEM 181991D 1.00
25 KONMAN 896802C 1.97 BISHAL GUPTA 162851D 3.11 MOHD SHAHEEN 475612D 0.74
26 KRISHNA SUMANTH 015891D 1.51 CHARAN K 562897C 3.81 MRIGANKA GUHA 306039C 1.05
27 VINAYAK 121664D 1.61 DEVIS BABY 233409D 5.49 NANCY'S BABY 144633D 1.52
28 VINEET VICTOR 036123D 3.23 IYANNER 308175D 12.26 PRASANTH 903316C 1.77
29 SUDIP DAS 765698C 1.71 INZAMAMUL HAQUE 186789D 2.88 PRETIVIRAJ 661842C 1.04
30 VIGNESH 522749B 5.56 JASIMUDDIN AHAMED 221705D 1.97 PUNITHA'S BABY 194272D 1.41
31 SELVI'S BABY 838989C 2.82 LOGNO SAHA 234192D 4.19 RAJDEEP PRAMANIK 709571D 0.89
32 SWAGATAM DAS MANDAL 965407C 3.95 MOHITH NAYAK 368276D 7.12 RAJDITYA GHORAI 299781D 1.58
33 TARNI SEN MANDAL 158360D 2.07 MD FARHAN RAJA 354727D 2.33 REETHAM KUNDU 163763D 1.20
34 SHAHEED BANDWA 426226C 1.86 MD ARSHAD 304492D 9.33 RIYAZ AHAMED 739908D 1.95
35 SURYA S 927255C 1.50 MANIGANDA PRABHU 176030D 2.72 ROUNAK DAS 111085D 1.61
36 ANANDA GIRI 436775D 3.06 MONU SAHA 196809D 3.25 SADH K 723102D 1.81
37 BHABATOSH 390506D 3.13 MALIKUNZA'S BABY 552290B 4.10 SAISARAN 430882D 0.95
38 DEVA 453779D 2.86 PRIYANSHU RAHA 262311D 4.08 SENTHIL KUMAR 326936C 1.38
39 ESTIAQUE.A 458458D 0.87 PUSKAR SAHA 74395D 3.63 SHAIKH RIZWAN AHAMED 439122D 1.82
40 GAUTHAM 940577C 1.44 RITAM GHOSH 268410D 1.97 SHANKARI'S BABY 994140C 1.42
41 JHUMA BAGACHI'S BABY 239030D 1.63 RAJDEEP NATH 265281D 10.42 SHARMA S R 073749D 2.08
42 KUMARAN 406579D 1.00 SURYA PRATAP 177758D 6.12 SOUMYAJYOTI MAITY 437002D 1.33
43 MAYANK SHARMA 384236D 2.99 YRAVA VINEET 195361D 3.04 SOURAV DATTA 673064D 1.26
44 MOHD SAINAN 652058B 5.30 SAIKAT PAUL 438923D 4.00 SUBHRAPRAKASH ROUT 190432D 0.54
45 NILESH KUMAR OJHA 564805D 1.02 SAFWAN AHAMED 452157D 13.91 TAMBIR 694097D 0.94
46 PRITAM C 555344D 1.34 PRIANTU SAHA 462339D 8.23 TARUN S 638356D 1.40
47 RANJITH  KUMAR 171030C 4.66 FATHIMAS BABY 501718D 11.36 USHA K'S BABY 720344C 1.05
48 SABITRIDEVI'S BABY 3970686C 3.89 ARNAB BAPLI 511503D 3.31 VIJAY T 674408D 1.00
49 SAMRAT GHOSH 481149D 4.93 VIMALAS BABY 850963C 5.62 VIJENDRA KUMAR 355576D 0.80
50 SAMU 598707D 5.23 ANIK BISWAS 436394D 3.84
51 SANTHANA KUMAR 386855D 5.08 MANOSH DAS 585766D 8.35
52 SHAHIL BURNWAL 426226C 2.76 SOUMYADEEP MANDAL 586906D 4.02
53 SHARIERAAHAMED 491208D 1.22 JAYAS BABY 400541D 3.34
54 SHUBHAM KUMAR 517658D 2.14 DIPAK KUMAR 410749D 5.71
55 SUDIP KUMAR 499755D 3.10 AMERENDER PRATAP 425046D 3.00
56 SUJAL GUPTA 440086D 3.05 SAYANDIP KANDAR 431737D 6.02
57 SUSHANT SHURAV 444227D 2.82 RAHUL DAS 431761D 1.58
58 TANMOY SAHA 396904D 2.82 PRIYAM J 335970D 2.34
59 USHA'S BABY 955364C 5.66 JAYANTIS BABY 480013D 3.10
60 VIJAY SARKAR RAMUL 512448D 1.64 SHIRINS BABY 498327D 8.58
61 VIJAYALAKSHMI'S BABY 029535D 2.79 SHANU DATTA 503480D 4.89
62 ADRITA DEB 743963C 3.92 DEBADRITO BHADURI 507299D 2.08
63 DEPARPAN MUKHERJEE 642833D 2.40 EVA BAREHS BABY 556218D 8.37
64 DINESH KUMAR YADAV 653744D 2.16 JIT SAHA 586810D 4.42
65 JAMES 433405C 3.23 GOKUL S 390786D 2.71
66 LALPEKHLUA 639592D 2.17 SULAIMAL NATCHI 646220D 4.62
67 PRIYANSHU 683355D 3.67 SABARI VASAN 670673D 5.33
68 RAGHAVI NATHAN 743295D 4.26 SUDIPTA MANDAL 703710D 5.98
69 SABARINATHAN T 696075D 1.85 SUMAN CHAKRABORTY 576713D 2.07
70 SHIVSAGAR SHAH 720259D 4.71 JUBIER AHMED 730893D 4.27
71 TORIQUL ISLAM 683878D 2.44 BITTU RAY 740525D 3.14
72 DEEPA'S BABY 499241C 3.92 CHAND ANSARI 781071D 4.02
73 ARNAB HOTA 819651D 4.08 ARGHA DAS 791292D 10.39
74 DIVYAS BABY 804789D 5.21
75 KIRANDEVIS BABY 804221D 7.50
NEUROGENIC BLADDER PUV CONTROL PATIENT (VUR)
 
SR.NO NAME HOSP NO RATIO NAME HOSP NO RATIO
1 GEETHA'S BABY 589608C 0.91 DEBASHISH SHAW 129817D 5.38
2  LATHA'S BABY 244473D 1.23 DISANT PRADHAN 003841D 6.81
3 AMIT MATHEW THOMAS 242207D 7.50 DHANUSH  806392D 3.16
4 KAVIYARASU 369214D 7.18 AMAN VERMA 169767D 4.92
5 DEBU HALDAR 199189D 4.86 AYAN KONAR 790466C 9.22
6 MUNNA KUMAR 321693D 2.11 MANOMAY CHAKRABORTY 509241C 2.59
7 DHANRAJ SARVESH 083763D 2.23 SABARNA KARMAKAR 798701D 1.77
8 MD.SHAHEED ALAM 338592D 2.54 RAMANA 915292C 7.07
9 SATHISH M 109534C 1.86 PARUEZ BADSHA 087170D 7.23
10 SUMATHIS BABY 405224C 1.03 PRADEEP 961355C 7.89
11 TANMAY SAHU 315567D 1.11 NITYA BERA 104512D 4.19
12 YUVRAJ 202545D 8.44 NITHISH KUMAR 078495D 13.53
13 VELMURUGAN 833388B 6.46 YASWANTH 033455D 6.08
14 RANGARAJ 267157D 2.39 VINAYAGAM 630448C 1.06
15 PRABHAVATHI'S BABY 235725C 2.08 USHAS BABY 955364C 4.29
16 RAJU 986509C 2.78 SHRIKANT JANA 989392C 6.01
17 JAMSHEDUDDIN 019336D 2.13 SREEJAN KESARI 168445D 1.23
18 RAJKUMAR 815795C 0.80 SUMAN SUTRADHAR 156299D 3.08
19 AYUSHKUMAR VARMA 090466D 1.20 SHAMEERA BANUS BABY 073037D 2.56
20 MALAY BERA 099149D 1.18 SUBRAJIT DEB 077900D 6.40
21 AKASH SARKAR 822076C 4.41 ASHOK RANJAN S 885484C 3.05
22 GEETHA'S BABY 034947C 1.01 ANBU D 238246D 3.94
23 MUKESHKUMAR 024609D 2.12 ANJALI DEVIS BABY 885965C 4.56
24 LIYAKAT ALI 962196C 3.00 BABU 245960D 5.28
25 KONMAN 896802C 1.97 BISHAL GUPTA 162851D 3.11
26 KRISHNA SUMANTH 015891D 1.51 CHARAN K 562897C 3.81
27 VINAYAK 121664D 1.61 DEVIS BABY 233409D 5.49
28 VINEET VICTOR 036123D 3.23 IYANNER 308175D 12.26
29 SUDIP DAS 765698C 1.71 INZAMAMUL HAQUE 186789D 2.88
30 VIGNESH 522749B 5.56 JASIMUDDIN AHAMED 221705D 1.97
31 SELVI'S BABY 838989C 2.82 LOGNO SAHA 234192D 4.19
32 SWAGATAM DAS MANDAL 965407C 3.95 MOHITH NAYAK 368276D 7.12
33 TARNI SEN MANDAL 158360D 2.07 MD FARHAN RAJA 354727D 2.33
34 SHAHEED BANDWA 426226C 1.86 MD ARSHAD 304492D 9.33
35 SURYA S 927255C 1.50 MANIGANDA PRABHU 176030D 2.72
36 ANANDA GIRI 436775D 3.06 MONU SAHA 196809D 3.25
37 BHABATOSH 390506D 3.13 MALIKUNZA'S BABY 552290B 4.10
38 DEVA 453779D 2.86 PRIYANSHU RAHA 262311D 4.08
39 ESTIAQUE.A 458458D 0.87 PUSKAR SAHA 74395D 3.63
40 GAUTHAM 940577C 1.44 RITAM GHOSH 268410D 1.97
41 JHUMA BAGACHI'S BABY 239030D 1.63 RAJDEEP NATH 265281D 10.42
42 KUMARAN 406579D 1.00 SURYA PRATAP 177758D 6.12
43 MAYANK SHARMA 384236D 2.99 YRAVA VINEET 195361D 3.04
44 MOHD SAINAN 652058B 5.30 SAIKAT PAUL 438923D 4.00
45 NILESH KUMAR OJHA 564805D 1.02 SAFWAN AHAMED 452157D 13.91
46 PRITAM C 555344D 1.34 PRIANTU SAHA 462339D 8.23
47 RANJITH  KUMAR 171030C 4.66 FATHIMAS BABY 501718D 11.36
48 SABITRIDEVI'S BABY 3970686C 3.89 ARNAB BAPLI 511503D 3.31
49 SAMRAT GHOSH 481149D 4.93 VIMALAS BABY 850963C 5.62
50 SAMU 598707D 5.23 ANIK BISWAS 436394D 3.84
NEUROGENIC BLADDER PUV
51 SANTHANA KUMAR 386855D 5.08 MANOSH DAS 585766D 8.35
52 SHAHIL BURNWAL 426226C 2.76 SOUMYADEEP MANDAL 586906D 4.02
53 SHARIERAAHAMED 491208D 1.22 JAYAS BABY 400541D 3.34
54 SHUBHAM KUMAR 517658D 2.14 DIPAK KUMAR 410749D 5.71
55 SUDIP KUMAR 499755D 3.10 AMERENDER PRATAP 425046D 3.00
56 SUJAL GUPTA 440086D 3.05 SAYANDIP KANDAR 431737D 6.02
57 SUSHANT SHURAV 444227D 2.82 RAHUL DAS 431761D 1.58
58 TANMOY SAHA 396904D 2.82 PRIYAM J 335970D 2.34
59 USHA'S BABY 955364C 5.66 JAYANTIS BABY 480013D 3.10
60 VIJAY SARKAR RAMUL 512448D 1.64 SHIRINS BABY 498327D 8.58
61 VIJAYALAKSHMI'S BABY 029535D 2.79 SHANU DATTA 503480D 4.89
62 ADRITA DEB 743963C 3.92 DEBADRITO BHADURI 507299D 2.08
63 DEPARPAN MUKHERJEE 642833D 2.40 EVA BAREHS BABY 556218D 8.37
64 DINESH KUMAR YADAV 653744D 2.16 JIT SAHA 586810D 4.42
65 JAMES 433405C 3.23 GOKUL S 390786D 2.71
66 LALPEKHLUA 639592D 2.17 SULAIMAL NATCHI 646220D 4.62
67 PRIYANSHU 683355D 3.67 SABARI VASAN 670673D 5.33
68 RAGHAVI NATHAN 743295D 4.26 SUDIPTA MANDAL 703710D 5.98
69 SABARINATHAN T 696075D 1.85 SUMAN CHAKRABORTY 576713D 2.07
70 SHIVSAGAR SHAH 720259D 4.71 JUBIER AHMED 730893D 4.27
71 TORIQUL ISLAM 683878D 2.44 BITTU RAY 740525D 3.14
72 DEEPA'S BABY 499241C 3.92 CHAND ANSARI 781071D 4.02
73 ARNAB HOTA 819651D 4.08 ARGHA DAS 791292D 10.39
74 DIVYAS BABY 804789D 5.21
75 KIRANDEVIS BABY 804221D 7.50
NAME HOSP NO RATIO
ADITYA KUMAR 217415D 1.06
AJAY PAUL 733425C 1.63
AMAN RAJ 782802D 1.02
ARIB NOOR FAROOQI 287000D 0.85
ARPIT RAJ 458298D 2.47
AYUSH KEDIA 386337D 1.18
BIKRAM RIT 331021D 1.76
BILOMBO BASAK 445039D 1.00
BIVEK KUMAR 704128D 1.30
CHITRAS BABY 629131D 1.08
DEEPAK M 210904D 1.03
DHEMAN ROY 254057D 0.98
DHINESH KUMAR 756190C 0.98
FERODES BEGAM'S BABY 859140C 0.92
GAURAV MASTER 594328D 1.17
HEENAKAR THAKUR 490448D 1.15
IBAN KITLANG 298651D 1.13
JASWANT S 472637D 1.17
KUTU 664852C 0.94
KRISHNENDU PAL 393686D 1.33
LACKI 116793D 1.03
MEERAJ MONDAL 535880D 1.16
MOHD AMASH 983190C 3.25
MOHD JASEEM 181991D 1.00
MOHD SHAHEEN 475612D 0.74
MRIGANKA GUHA 306039C 1.05
NANCY'S BABY 144633D 1.52
PRASANTH 903316C 1.77
PRETIVIRAJ 661842C 1.04
PUNITHA'S BABY 194272D 1.41
RAJDEEP PRAMANIK 709571D 0.89
RAJDITYA GHORAI 299781D 1.58
REETHAM KUNDU 163763D 1.20
RIYAZ AHAMED 739908D 1.95
ROUNAK DAS 111085D 1.61
SADH K 723102D 1.81
SAISARAN 430882D 0.95
SENTHIL KUMAR 326936C 1.38
SHAIKH RIZWAN AHAMED 439122D 1.82
SHANKARI'S BABY 994140C 1.42
SHARMA S R 073749D 2.08
SOUMYAJYOTI MAITY 437002D 1.33
SOURAV DATTA 673064D 1.26
SUBHRAPRAKASH ROUT 190432D 0.54
TAMBIR 694097D 0.94
TARUN S 638356D 1.40
USHA K'S BABY 720344C 1.05
VIJAY T 674408D 1.00
VIJENDRA KUMAR 355576D 0.80
CONTROL PATIENT (VUR)
SR.NO HOSP NO NAME AGE CAUSE OF NB U.R HN
1 589608C GEETHA'S BABY 4 1 0.909091 2
2 244473D  LATHA'S BABY 1 1 1.234615 2
3 242207D AMIT MATHEW THOMAS 3 2 7.5 2
4 369214D KAVIYARASU 13 1 7.183099 1
5 199189D DEBU HALDAR 0.5 1 4.860465 2
6 321693D MUNNA KUMAR 12 1 2.105263 1
7 083763D DHANRAJ SARVESH 3 3 2.232143 2
8 338592D MD.SHAHEED ALAM 6 1 2.538462 1
9 109534C SATHISH M 6 1 1.861111 1
10 405224C SUMATHIS BABY 3 1 1.025641 2
11 315567D TANMAY SAHU 14 2 1.105528 1
12 202545D YUVRAJ 10 1 8.444444 1
13 833388B VELMURUGAN 8 1 6.463158 2
14 267157D RANGARAJ 10 1 2.391304 2
15 235725C PRABHAVATHI'S BABY 6 1 2.082927 2
16 986509C RAJU 5 1 2.78022 1
17 019336D JAMSHEDUDDIN 7 3 2.125984 1
18 815795C RAJKUMAR 1 1 0.8 2
19 090466D AYUSHKUMAR VARMA 2 1 1.20202 2
20 099149D MALAY BERA 1 1 1.18239 2
21 822076C AKASH SARKAR 2 1 4.409091 1
22 034947C GEETHA'S BABY 5 1 1.006623 2
23 024609D MUKESHKUMAR 8 1 2.120482 2
24 962196C LIYAKAT ALI 8 1 3 2
25 896802C KONMAN 2 1 1.966292 2
26 015891D KRISHNA SUMANTH 15 1 1.51375 2
27 121664D VINAYAK 12 1 1.611289 1
28 036123D VINEET VICTOR 6 1 3.227513 1
29 765698C SUDIP DAS 2.5 1 1.706093 2
30 522749B VIGNESH 11 1 5.560811 2
31 838989C SELVI'S BABY 1 4 2.818182 1
32 965407C SWAGATAM DAS MANDAL 2 1 3.945 2
33 158360D TARNI SEN MANDAL 12 1 2.07029 2
34 426226C SHAHEED BANDWA 3.5 1 1.864489 2
35 927255C SURYA S 5 1 1.497485 2
36 436775D ANANDA GIRI 8 1 3.055556 1
37 390506D BHABATOSH 13 3 3.132552 1
38 453779D DEVA 9 1 2.857143 1
39 458458D ESTIAQUE.A 8 1 0.866667 2
40 949577C GAUTHAM 4 4 1.441176 2
41 239030D JHUMA BAGACHI'S BABY 1 1 1.628788 1
42 406579D KUMARAN 2 3 1 2
43 384236D MAYANK SHARMA 3 1 2.988372 2
44 652058B MOHD SAINAN 6 1 5.302419 1
45 564805D NILESH KUMAR OJHA 2 2 1.022222 2
46 555344D PRITAM C 8 1 1.337079 2
47 171030C RANJITH  KUMAR 8 1 4.66055 2
48 3970686C SABITRIDEVI'S BABY 5 1 3.891176 2
49 481149D SAMRAT GHOSH 2 1 4.929293 2
50 598707D SAMU 14 1 5.226415 1
51 386855D SANTHANA KUMAR 9 1 5.075 2
52 426226C SHAHIL BURNWAL 5 1 2.757396 2
53 491208D SHARIERAAHAMED 8 1 1.223404 2
54 517658D SHUBHAM KUMAR 14 1 2.137931 2
55 499755D SUDIP KUMAR 4 2 3.10101 2
56 440086D SUJAL GUPTA 1 2 3.053846 2
57 444227D SUSHANT SHURAV 5 1 2.817647 2
58 396904D TANMOY SAHA 7 5 2.824818 2
59 955364C USHA'S BABY 0.5 1 5.658824 1
60 512448D VIJAY SARKAR RAMUL 4 1 1.64 2
61 029535D VIJAYALAKSHMI'S BABY 2 1 2.7875 2
62 743963C ADRITA DEB 8 3 3.919753 2
63 642833D DEPARPAN MUKHERJEE 2 3 2.398333 2
64 653744D DINESH KUMAR YADAV 10 1 2.163636 2
65 433405C JAMES 6 1 3.234043 2
66 639592D LALPEKHLUA 2.5 1 2.171429 2
67 683355D PRIYANSHU 7 1 3.666667 2
68 743295D RAGHAVI NATHAN 0.8 4 4.26 2
69 696075D SABARINATHAN T 12 1 1.852174 2
70 720259D SHIVSAGAR SHAH 14 5 4.707071 1
71 683878D TORIQUL ISLAM 8 3 2.437403 1
72 499241C DEEPA'S BABY 5 1 3.918083 2
73 819651D ARNAB HOTA 1 1 4.081244 2
BLD TRAB REFLUX PU DILN CREAT PVR TREATMENT CMG
1 2 2 0.5 1 1 1
2 2 2 0.4 2 1
1 2 2 0.5 1 2
1 2 1 0.7 1 2
2 1 1 0.4 1 1
1 1 2 2.4 1 1
2 2 2 0.5 1 1
1 1 2 0.8 1 5
1 2 1 0.6 1 5
2 2 2 0.4 1 1
1 2 2 0.6 1 2
1 2 1 0.8 1 1
1 2 1 0.6 1 1
1 2 1 0.5 2 2
2 2 1 0.6 2 6
1 1 2 0.6 2 6
1 2 2 0.5 2 1
2 2 2 0.4 2 1 1
2 2 2 0.4 1 3
2 2 2 0.4 1 2
1 1 1 0.7 2 6
2 2 2 0.5 2 4 2
1 2 1 0.7 1 1
1 2 1 0.5 1 2
2 2 2 0.4 2 1
2 2 2 0.6 2 1 2
1 1 2 0.4 1 1
1 2 1 0.5 2 2 2
2 2 2 0.4 1 2
2 2 1 0.6 2 6
1 1 1 0.5 2 1
1 2 1 0.4 1 2 2
2 2 2 0.5 1 1
2 2 1 0.4 1 1
2 2 2 0.5 2 2
1 1 + 0.6 2 6
1 1 1 1.6 2 6 2
1 2 1 1.4 2 1 2
1 1 2 0.6 2 2
1 1 2 0.4 1 5 2
2 1 1 0.4 2 5
1 2 2 0.4 2 1
2 2 1 0.5 2 2
1 2 1 0.5 1 2
1 2 2 0.4 1 1
2 2 2 0.7 1 1 1
1 2 1 0.6 1 1 2
1 2 1 0.6 1 2 2
1 2 1 0.4 1 2
1 2 1 0.6 1 2 2
1 2 1 0.5 2 2
2 2 2 0.4 1 2
1 2 2 0.6 1 2
1 2 1 0.6 1 4
1 2 1 0.6 1 4 1
2 2 1 0.5 2 1
2 1 2 0.5 1 2
2 2 1 0.6 1 4
2 2 + 0.5 2 2
2 1 2 0.4 1 2
1 1 1 0.5 1 1 1
1 2 1 0.5 2 2 2
1 2 2 0.5 2 4 2
1 1 1 0.6 2 3
1 2 1 0.5 2 1 2
1 1 2 0.5 2 2 2
1 2 1 0.6 1 1 2
2 2 1 0.5 1 1
1 1 2 0.6 2 1
1 2 1 1 1 2 2
2 1 2 0.6 2 2
1 1 2 0.7 2 1
2 2 2 0.4 2 3 2
P.U A.U
21 23.1
32.1 26
60 8
51 7.1
41.8 8.6
24 11.4
25 11.2
33 13
6.7 3.6
12 11.7
22 19.9
30.4 3.6
61.4 9.5
33 13.8
42.7 20.5
25.3 9.1
27 12.7
22 27.5
11.9 9.9
18.8 15.9
67.9 15.4
15.2 15.1
52.8 24.9
24 8
17.5 8.9
12.11 8
30.26 18.78
61 18.9
47.6 27.9
82.3 14.8
27.9 9.9
7.89 2
28.57 13.8
53.66 28.78
26.79 17.89
55 18
34.74 11.09
40 14
6.5 7.5
9.8 6.8
21.5 13.2
25.3 25.3
25.7 8.6
52.6 9.92
10.12 9.9
11.9 8.9
50.8 10.9
39.69 10.2
48.8 9.9
27.7 5.3
40.6 8
46.6 16.9
11.5 9.4
24.8 11.6
30.7 9.9
39.7 13
19.16 6.8
38.7 13.7
48.1 8.5
16.4 10
22.3 8
31.75 8.1
28.78 12
35.7 16.5
45.6 14.1
22.8 10.5
25.3 6.9
42.6 10
21.3 11.5
46.6 9.9
15.77 6.47
25.35 6.47
40.69 9.97
                     
                         CONTROL 
 
                    
                      NB 
 
                   
                     PUV 
 
 
LOWER LIMIT OF URETHRAL RATIO IN EACH GROUP. 
                        
                    CONTROL 
 
                        
                          NB 
 
                        
                          PUV 
 
                   
                         MEAN  URETHRAL RATIO IN EACH GROUP 
                
                   CONTROL 
 
                
                    NB 
 
                 
                    PUV 
 
 
           UPPER LIMIT OF URETHRAL RATIO IN EACH GROUP. 
                 CORRELATION OF URETHRAL RATIO WITH USG AND CMG  
 
                                      
       MCU:  Nondilated posterior urethra 
 
                
                                            USG : No Upper Tract  Changes 
 
                
CMG: Good compliant Bladder 
            CORRELATION OF URETHRAL RATIO WITH USG AND CMG : 
 
                                                       
 
MCU: Dilated posterior urethra                     USG:Hydroureteronephrosis   
 
 
 
 
     
 
 CMG :  Poor compliant ,high pressure bladder with DESD 
